Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 269

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 269
---
 a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

<div align='center'>II-4

SIGNATURES</div>

Pursuant to the requirements
of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on the Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in Hong Kong, on the November 19, 2025.

| Living                        
 Homeopathy International Ltd. |                   |
| By:                           | /s/ Ka Lun To     |
|                               | Ka                
 Lun To            |
|                               | Chief             
 Executive Officer |

Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities
and on November 19, 2025.

| Signature            |     | Title                                       |
| /s/ Ka Lun To        |     | Chief Executive Officer,                    |
| Ka Lun To            |     | -Principal Executive Officer                |
| *                    |     | Chief Financial Officer,                    |
| Cheuk Fei Jeffrey Lo |     | -Principal Financial and Accounting Officer |
| *                    |     | Director                                    |
| Lee Shing Hei        |     |                                             |
| *By: Ka Lun To       |     |                                             |
| Name:                
 Ka Lun To            |     |                                             |
| Attorney-in-fact     |     |                                             |

<div align='center'>II-5

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</div>

Pursuant to the Securities
Act of 1933 as amended, the undersigned, the duly authorized representative in the United States of America, has signed this registration
statement ther